Aryastha Life Sciences Announces Elite Executive Team
Aryastha Life Sciences, a leading Contract Research, Development, and Manufacturing Organization, is excited to introduce its new executive team. This experienced group aims to spearhead the company’s Integrated Drug Discovery and Development strategy, showcasing a commitment to enhance the company's scientific vision.
Leadership Experience and Achievements
The new leadership team boasts a wealth of experience, having successfully filed 11 Investigational New Drug Applications (INDs), developed 6 clinical candidates, and managed over 75 integrated drug discovery projects across diverse therapeutic areas. Dr. Raghava Reddy Kethiri, Co-founder and CEO, emphasizes the company's unique position in the market. He states, "There is no other company working with a biotech mindset and offering intellectual solutions like Aryastha, particularly in the realm of translational science."
Dr. Ram Shankar Upadhayaya: Chief Technology Officer
Dr. Ram Shankar Upadhayaya steps into the role of Chief Technology Officer, bringing more than 24 years of expertise in the pharmaceutical sector. He recently obtained a Doctor of Science degree and has a Ph.D. in Medicinal Chemistry. With a notable background in RNA and Structural Biology from Uppsala University, Sweden, he is well-equipped for this position.
Focus on New Drug Discovery
Dr. Upadhayaya is a recognized visionary in new drug discovery, specializing in critical areas such as oncology, autoimmune diseases, metabolic disorders, and infectious diseases. His career highlights include significant funding acquisitions and leading global multidisciplinary teams, aimed at bridging the gap between academia and industry. He expresses enthusiasm about joining Aryastha, stating, "Our innovative technology platforms enhance predictability from 'molecule to medicine', ensuring clinical success."
Other Key Appointments
Laura Sailor: Chief Business Officer
Joining Aryastha as Chief Business Officer, Laura Sailor brings over 30 years of industry knowledge. A graduate from Saint Joseph's College, she is renowned for her entrepreneurial spirit and exceptional track record in establishing successful Contract Research Organizations (CROs) across the globe.
Dr. Gnaneswar Atturu: Chief Clinical Advisor
Dr. Gnaneswar Atturu, a prominent clinical scientist and Senior Vascular & Endovascular Surgeon, has extensive experience in both India and the UK, totaling over 25 years. His qualifications include MRCS, FRCS, Ch.M, and MBA, with the prestigious James Hogarth Pringles Gold Medal awarded by the Royal College of Edinburgh. Dr. Atturu is not only a clinician but also an active contributor to academic literature, having authored books and published multiple peer-reviewed articles.
About Aryastha Life Sciences
Aryastha Life Sciences is committed to life sciences innovation, delivering solutions for novel drug development. The company aims to make significant strides in the field of medical research and development, advancing the health and well-being of patients worldwide.
Frequently Asked Questions
What is the main focus of Aryastha Life Sciences?
Aryastha Life Sciences focuses on integrated drug discovery and development, aiming to offer innovative solutions in the pharmaceutical sector.
Who is Dr. Ram Shankar Upadhayaya?
Dr. Ram Shankar Upadhayaya is the Chief Technology Officer at Aryastha Life Sciences, bringing significant expertise in drug discovery and medicinal chemistry.
What experience does Laura Sailor bring as Chief Business Officer?
Laura Sailor brings over 30 years of industry experience and is known for her successful track record in establishing CROs globally.
Who is Dr. Gnaneswar Atturu?
Dr. Gnaneswar Atturu is the Chief Clinical Advisor at Aryastha, with extensive clinical experience and numerous scholarly contributions in the field.
What is Aryastha's mission?
Aryastha aims to advance drug development solutions, focusing on innovation and collaboration to enhance patient outcomes.
